Cargando…

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial

BACKGROUND: Even though the efficacy of Intermittent Preventive Treatment in infants (IPTi) with Sulfadoxine-Pyrimethamine (SP) against clinical disease and the absence of its interaction with routine vaccines of the Expanded Immunization Programme (EPI) have been established, there are still some c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dicko, Alassane, Toure, Sidy O, Traore, Mariam, Sagara, Issaka, Toure, Ousmane B, Sissoko, Mahamadou S, Diallo, Alpha T, Rogier, Christophe, Salomon, Roger, de Sousa, Alexandra, Doumbo, Ogobara K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155918/
https://www.ncbi.nlm.nih.gov/pubmed/21767403
http://dx.doi.org/10.1186/1471-2458-11-573
_version_ 1782210167711989760
author Dicko, Alassane
Toure, Sidy O
Traore, Mariam
Sagara, Issaka
Toure, Ousmane B
Sissoko, Mahamadou S
Diallo, Alpha T
Rogier, Christophe
Salomon, Roger
de Sousa, Alexandra
Doumbo, Ogobara K
author_facet Dicko, Alassane
Toure, Sidy O
Traore, Mariam
Sagara, Issaka
Toure, Ousmane B
Sissoko, Mahamadou S
Diallo, Alpha T
Rogier, Christophe
Salomon, Roger
de Sousa, Alexandra
Doumbo, Ogobara K
author_sort Dicko, Alassane
collection PubMed
description BACKGROUND: Even though the efficacy of Intermittent Preventive Treatment in infants (IPTi) with Sulfadoxine-Pyrimethamine (SP) against clinical disease and the absence of its interaction with routine vaccines of the Expanded Immunization Programme (EPI) have been established, there are still some concerns regarding the addition of IPTi, which may increase the work burden and disrupt the routine EPI services especially in Africa where the target immunization coverage remains to be met. However IPTi may also increase the adherence of the community to EPI services and improve EPI coverage, once the benefice of strategy is perceived. METHODS: To assess the impact of IPTi implementation on the coverage of EPI vaccines, 22 health areas of the district of Kolokani were randomized at a 1:1 ratio to either receive IPTi-SP or to serve as a control. The EPI vaccines coverage was assessed using cross-sectional surveys at baseline in November 2006 and after one year of IPTi pilot-implementation in December 2007. RESULTS: At baseline, the proportion of children of 9-23 months who were completely vaccinated (defined as children who received BGG, 3 doses of DTP/Polio, measles and yellow fever vaccines) was 36.7% (95% CI 25.3% -48.0%). After one year of implementation of IPTi-SP using routine health services, the proportion of children completely vaccinated rose to 53.8% in the non intervention zone and 69.5% in the IPTi intervention zone (P <0.001). The proportion of children in the target age groups who received IPTi with each of the 3 vaccinations DTP2, DTP3 and Measles, were 89.2% (95% CI 85.9%-92.0%), 91.0% (95% CI 87.6% -93.7%) and 77.4% (95% CI 70.7%-83.2%) respectively. The corresponding figures in non intervention zone were 2.3% (95% CI 0.9% -4.7%), 2.6% (95% CI 1.0% -5.6%) and 1.7% (95% CI 0.4% - 4.9%). CONCLUSION: This study shows that high coverage of the IPTi can be obtained when the strategy is implemented using routine health services and implementation results in a significant increase in coverage of EPI vaccines in the district of Kolokani, Mali. TRIAL REGISTRATION: ClinicalTrials.gov NCT00766662
format Online
Article
Text
id pubmed-3155918
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31559182011-08-16 Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial Dicko, Alassane Toure, Sidy O Traore, Mariam Sagara, Issaka Toure, Ousmane B Sissoko, Mahamadou S Diallo, Alpha T Rogier, Christophe Salomon, Roger de Sousa, Alexandra Doumbo, Ogobara K BMC Public Health Research Article BACKGROUND: Even though the efficacy of Intermittent Preventive Treatment in infants (IPTi) with Sulfadoxine-Pyrimethamine (SP) against clinical disease and the absence of its interaction with routine vaccines of the Expanded Immunization Programme (EPI) have been established, there are still some concerns regarding the addition of IPTi, which may increase the work burden and disrupt the routine EPI services especially in Africa where the target immunization coverage remains to be met. However IPTi may also increase the adherence of the community to EPI services and improve EPI coverage, once the benefice of strategy is perceived. METHODS: To assess the impact of IPTi implementation on the coverage of EPI vaccines, 22 health areas of the district of Kolokani were randomized at a 1:1 ratio to either receive IPTi-SP or to serve as a control. The EPI vaccines coverage was assessed using cross-sectional surveys at baseline in November 2006 and after one year of IPTi pilot-implementation in December 2007. RESULTS: At baseline, the proportion of children of 9-23 months who were completely vaccinated (defined as children who received BGG, 3 doses of DTP/Polio, measles and yellow fever vaccines) was 36.7% (95% CI 25.3% -48.0%). After one year of implementation of IPTi-SP using routine health services, the proportion of children completely vaccinated rose to 53.8% in the non intervention zone and 69.5% in the IPTi intervention zone (P <0.001). The proportion of children in the target age groups who received IPTi with each of the 3 vaccinations DTP2, DTP3 and Measles, were 89.2% (95% CI 85.9%-92.0%), 91.0% (95% CI 87.6% -93.7%) and 77.4% (95% CI 70.7%-83.2%) respectively. The corresponding figures in non intervention zone were 2.3% (95% CI 0.9% -4.7%), 2.6% (95% CI 1.0% -5.6%) and 1.7% (95% CI 0.4% - 4.9%). CONCLUSION: This study shows that high coverage of the IPTi can be obtained when the strategy is implemented using routine health services and implementation results in a significant increase in coverage of EPI vaccines in the district of Kolokani, Mali. TRIAL REGISTRATION: ClinicalTrials.gov NCT00766662 BioMed Central 2011-07-18 /pmc/articles/PMC3155918/ /pubmed/21767403 http://dx.doi.org/10.1186/1471-2458-11-573 Text en Copyright ©2011 Dicko et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dicko, Alassane
Toure, Sidy O
Traore, Mariam
Sagara, Issaka
Toure, Ousmane B
Sissoko, Mahamadou S
Diallo, Alpha T
Rogier, Christophe
Salomon, Roger
de Sousa, Alexandra
Doumbo, Ogobara K
Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
title Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
title_full Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
title_fullStr Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
title_full_unstemmed Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
title_short Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
title_sort increase in epi vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with sulfadoxine -pyrimethamine in the district of kolokani, mali: results from a cluster randomized control trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155918/
https://www.ncbi.nlm.nih.gov/pubmed/21767403
http://dx.doi.org/10.1186/1471-2458-11-573
work_keys_str_mv AT dickoalassane increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT touresidyo increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT traoremariam increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT sagaraissaka increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT toureousmaneb increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT sissokomahamadous increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT dialloalphat increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT rogierchristophe increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT salomonroger increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT desousaalexandra increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial
AT doumboogobarak increaseinepivaccinescoverageafterimplementationofintermittentpreventivetreatmentofmalariaininfantwithsulfadoxinepyrimethamineinthedistrictofkolokanimaliresultsfromaclusterrandomizedcontroltrial